At Synteract, we possess a deep understanding of the immune system and the body’s inflammatory responses. From innovative study design to in-depth feasibility analysis, our team of experts exhibit the essential knowledge needed to advance drug developers through the clinical development process.
Our comprehensive focus on allergy and immune-related disorders have helped to establish our rich portfolio of Immunology & Inflammatory experience, addressing today’s leading immune and inflammatory conditions. Synteract possesses proven experience amongst a variety of indications, across all phases of development, intersecting with several of our core centers of development such as dermatology, gastroenterology, infectious disease & vaccines, neuroscience, pediatrics, rare and orphan diseases, and women’s health.
- Allergic Rhinoconjunctivitis
- Biliary Cholangitis
- Crohn’s Disease
- Eosinophilic Esophagitis
- Guillain-Barre Syndrome
- Hereditary Angioedema
- Influenza
- Multiple Sclerosis
- Myasthenia Gravis
- Plaque Psoriasis
- Psoriasis
- Rheumatoid Arthritis
- Sarcoidosis
- Still’s Disease
- Systemic Sclerosis
- Vaccine
Learn more about how we bring your Immunology & Inflammatory clinical trials to life!
Contact Us